★★★★

UTI

UTI Q1 2026: Net Loss of 15.2B Won, Credit Rating Downgraded to CCC-


  • Consolidated sales: 4.77B won (vs 4.71B won YoY), operating loss 13.18B won, net loss 15.25B won, basic EPS -779 won
  • Credit rating downgraded to CCC- (April 2026, NICE)
  • Total liabilities 174.2B won, equity 56.4B won, debt ratio 309%
  • Five CB/EB issues totaling 132.65B won, derivative liabilities 61.57B won
  • Heavy capex at Vietnam subsidiary (UTI VINA VINH PHUC) with construction in progress of 37.6B won
  • Flexible glass planned for mass production in H2 2026; developing next-gen technologies like TGV
  • One pending lawsuit (165M won), company expects no material impact
  • Treasury shares 210,101 held (related to exchangeable bonds), no dividends
  • Standalone net profit of 0.73B won (vs -5.63B won YoY, turnaround) but consolidated still deep in red
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: UTI (179900)
  • Submission: UTI INC.
  • Receipt: 05-15-2026